Association between healthcare practitioners' beliefs about statins and patients' beliefs and adherence

Autor: Liset van Dijk, Bartholomeus Johannes Fredericus van den Bemt, Cornelia H. M. van den Ende, Victor J. B. Huiskes, David M. Burger
Přispěvatelé: RS: Carim - V01 Vascular complications of diabetes and metabolic syndrome, Clinical Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET)
Rok vydání: 2021
Předmět:
Male
pharmacy
Health Knowledge
Attitudes
Practice

medicine.medical_specialty
education
Pharmacy
Primary care
Pharmacists
030226 pharmacology & pharmacy
LONG-TERM PERSISTENCE
law.invention
Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]
statins
03 medical and health sciences
primary care
0302 clinical medicine
law
Surveys and Questionnaires
Health care
medicine
Humans
Pharmacology (medical)
030212 general & internal medicine
adherence
Association (psychology)
Aged
Pharmacology
general practice
RISK
ischemic-heart-disease
therapy
Clinical pharmacology
business.industry
Mean age
Multilevel regression
Cross-Sectional Studies
lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]
PERSPECTIVES
Family medicine
cardiology
MEDICINES
General practice
medication adherence
Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5]
Female
clinical pharmacology
Hydroxymethylglutaryl-CoA Reductase Inhibitors
business
Zdroj: British Journal of Clinical Pharmacology, 87(3), 1082-1088. Wiley
British Journal of Clinical Pharmacology, 87, 3, pp. 1082-1088
British Journal of Clinical Pharmacology, 87, 1082-1088
British Journal of Clinical Pharmacology, 87(3). Wiley
ISSN: 0306-5251
Popis: Contains fulltext : 232373.pdf (Publisher’s version ) (Closed access) AIMS: Adherence to statins ranges from 32% to 79%. Patients' beliefs about medication are associated with adherence. There is lack of insight into the possible association between beliefs of healthcare practitioners (HCPs) about statins and patients' beliefs and adherence. This study aims to examine whether HCPs' beliefs about statins are associated with patients' beliefs and adherence about/to statins. METHODS: Cross-sectional study in 48 pharmacies and affiliated physicians' practices between 3 September 2014 and 20 March 2015. HCPs' (prescribers and pharmacy staff) and patients' beliefs about statins were assessed with the Beliefs about Medicine Questionnaire (BMQ) specific. Adherence to statins was assessed with the MARS-5 questionnaire. Multilevel regression analysis was performed to assess the association between HCPs' beliefs and patients' beliefs and adherence. RESULTS: 1504 patients (mean age 66.8 [s.d. ± 9.9] years, 46.5% female) and 734 HCPs (209 physicians, 118 pharmacists and 366 pharmacy technicians) participated in this study. Patients have higher BMQ necessity (16.9 [s.d. ± 4.3]) and BMQ concern (12.3 [s.d. ± 3.9]) scores than HCPs (15.0 [s.d. ± 3.0] and 11.5 [s.d. ± 2.9], P < 0.001). No associations were found between any of the HCPs' BMQ and patients' BMQ scores and adherence to statins. Patients' BMQ necessity, concern and necessity-concerns (NC)-differential scores were associated with patients' adherence (MARS-5) scores. B (95% CI) coefficients were 0.057 (0.035-0.079), -0.040 (-0.064 to -0.016) and.061 (0.043-0.079). CONCLUSIONS: Patients have stronger beliefs about medication compared to HCPs. No associations were found between HCPs' BMQ scores on the one hand and patients' BMQ scores and adherence to statins on the other hand.
Databáze: OpenAIRE